Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. ARVN

Market Cap: $545.2M

AI

Arvinas, Inc.

ARVN
NASDAQ (NASDAQ Global Select)USD
Purchase ARVN
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin96.43%
EBITDA Margin0.92%
EBIT Margin-0.28%
Pre-tax Margin3.19%
Net Profit Margin2.94%
Earnings Yield1.70%
Valuation Multiples
Price / Book0.97
Price / Sales1.72
Price / Earnings44.47
PEG-0.24
Forward PEG0.01
EV / Sales1.45
EV / EBITDA158.31
EV / Operating Cash Flow-2.22
EV / Free Cash Flow-2.20
Price / Free Cash Flow-2.61
Price / Operating Cash Flow-2.65
Cash Flow & Capital
Free Cash Flow / Share-$3.22
Operating Cash Flow / Share-$3.19
Free Cash Flow Yield-38.30%
Capex / Revenue0.57%
Capex / Operating Cash Flow-0.87%
Capex / Depreciation0.23
Stock Compensation / Revenue8.15%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio7.91
Quick Ratio7.91
Cash Ratio1.14
Debt / Assets0.01
Debt / Capital0.01
Debt / Equity0.01
Long-Term Debt / Capital0.00
Debt / Market Cap0.09%
Net Debt / EBITDA-29.69
Solvency Ratio0.12
Financial Leverage1.20
Efficiency & Working Capital
Asset Turnover0.47
Fixed Asset Turnover25.75
Inventory Turnover0.00
Receivables Turnover5.83
Payables Turnover1.51
Days Sales Outstanding62.58
Days Inventory Outstanding0
Days Payables Outstanding242.26
Operating Cycle62.58
Cash Conversion Cycle-179.68
Working Capital Turnover0.58
Returns & Quality
Return on Equity1.91%
Return on Assets1.38%
Return on Invested Capital-2.18%
ROCE-2.38%
Return on Tangible Assets1.38%
Operating Return on Assets-2.13%
Income Quality-22.26
Tax Burden0.92
Interest Burden-11.22
Balance Sheet & Intrinsic Metrics
Enterprise Value$459.1M
Invested Capital$582M
Working Capital$569.7M
Tangible Asset Value$562.2M
Net Current Asset Value$539.3M
Graham Number$5.29
Graham Net-Net$7.65
Book Value / Share$8.68
Tangible Book Value / Share$8.68
Cash / Share$8.76
Financial Health Scores
Piotroski Score6
Altman Z-Score1.35
Revenue$316.7M
EBIT$-900K
Market Cap$561.98M
Working Capital$569.7M
Retained Earnings$-1.5B
Total Assets$675.1M
Total Liabilities$112.9M